NIT Rourkela Patents Pumpkin Petal-Silk Protein Formulation for Skin Cancer Treatment
- byDoctor News Daily Team
- 24 September, 2025
- 0 Comments
- 0 Mins
Bhubaneswar: In a significant scientific development, researchers at the National Institute of Technology (NIT) Rourkela have patented a novel formulation for the treatment of skin cancer, developed from an unusual yet powerful combination of pumpkin petal extracts and silk proteins. As per a recent media report in The Times of India, the formulation harnesses the natural antioxidant and anti-cancer properties of pumpkin petals, while silk proteins provide exceptional biocompatibility and structural strength. To enhance effectiveness, the team has incorporated a nanofiber-based delivery system, allowing precise targeting of cancerous cells and minimizing toxic side effects often associated with conventional treatments. According to the researchers, this innovation is not only eco-friendly and sustainable but also holds the potential to serve as a cost-effective alternative for millions of patients battling skin cancer. The patented technology has already undergone several stages of validation, paving the way for further development toward clinical application. Times of Indiareports that this patent marks a major step forward in leveraging natural resources and advanced biomaterials to design therapies that could transform cancer care in India and beyond.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!